» Authors » Zhi-Xiang Qiu

Zhi-Xiang Qiu

Explore the profile of Zhi-Xiang Qiu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 40
Citations 53
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang B, Liu Z, Wang Q, Liu W, Tang B, Qiu Z, et al.
Chin Med J (Engl) . 2020 Dec; 134(10):1230-1232. PMID: 33273371
No abstract available.
2.
Ou J, Gao S, Wang L, Zhang J, Nong L, Liu W, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2019 Jun; 27(3):796-801. PMID: 31204934
Objective: To investigate the clinical manifestations pathologic features, treatment options and prognosis of patients with bone lymphoma. Methods: The clinical characteristics, pathologic features, treatment and prognosis of 34 BL patients...
3.
Wang Z, Liu H, Ma N, Wang L, Liu W, Tang B, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2018 Oct; 26(5):1559-1564. PMID: 30295284
Objective: To investigate the expression of CD160 on the surface of human natural killer (NK) cells and its possible relationship with hematological malignancies. Methods: CD160 expression on human leukemia cell...
4.
Chen Q, Zhu L, Cen X, Liang Z, Ou J, Wang L, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2018 Jun; 26(3):765-771. PMID: 29950217
Objective: To analyze the incidence of bone marrow involvement in patients with different pathological types of lymphoma. Methods: The results of bone marrow tests including bone marrow aspiration(BMA), flow cytometry...
5.
Wang Q, Li Y, Ji L, Liang Z, Liu W, Ren H, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2018 Feb; 26(1):8-15. PMID: 29397811
Objective: To investigate the expression level of HB-1 gene in patients with acute lymphoblastic leukemia (ALL) and the significance of HB-1 gene in monitoring of minimal residual disease (MRD). Methods:...
6.
Wang M, Hu J, Qiu Z, Liu W, Wang M, Li Y, et al.
Clin Immunol . 2017 Oct; 191:81-87. PMID: 28965881
To investigate the effects of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on chemokine receptors and explore the potential mechanism of rhG-CSF inducing immune tolerance, ninety-seven donor and recipient pairs undergoing...
7.
Zhu L, Cen X, Ou J, Qiu Z, Wang L, Liu W, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2017 Apr; 25(2):431-437. PMID: 28446288
Objective: To explore the prognostic value of interim F-FDG PET/CT (i-PET/CT) scan for the patients with newly diagnosed diffuse large B-cell lymphoma (DLBCL). Methods: A total of 70 cases of...
8.
Yin Y, Qiu Z, Li Y, Xu W, Sun Y, Liu W, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2017 Apr; 25(2):418-425. PMID: 28446286
Objective: To assess the safety and efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in treating patients with relapsed and refractory lymphoma. Methods: Thirty-one consecutive patients with relapsed or refractory...
9.
Qiu Q, Zhu P, Wang M, Lu X, Dong Y, Sun Y, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2016 Aug; 24(4):1071-8. PMID: 27531777
Objective: To study the relationship between surface markers of CD56 and CD19 and karyotypes and prognosis in multiple myeloma. Methods: A total of 126 cases of newly diagnosed multiple myeloma...
10.
Wang M, Dong Y, Qiu Z, Liu W, Ren H
Zhongguo Shi Yan Xue Ye Xue Za Zhi . 2016 Jun; 24(3):833-9. PMID: 27342519
Objective: To summarize the clinical experience and evaluate the efficacy of haploidentical HSCT. Methods: The survival rates of 156 patients receiving either haploidentical (83 cases) or HLA-identical (73 cases) transplantation...